{"entity":{"type":"insider","cik":"0001341011","url":"/insider/0001341011","json_url":"/insider/0001341011.json","name":"North Annette","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":5,"first":"2021-02-02","last":"2022-02-11","span_basis":"filed_date"},"name_variants":[{"name":"North Annette","source":"filing","n_filings":5,"first_seen":"2021-02-02","last_seen":"2022-02-11"}],"transactions":[{"id":6481035,"accession":"0001209191-22-008981","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-008981","line_url":"/filing/0001209191-22-008981#line-2","is_derivative":false,"issuer_cik":"0001341011","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001341011","owner_cik":"0001341011","owner_name":"North Annette","owner_display_name":"North Annette","owner_url":"/insider/0001341011","role":"Officer (EVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":669.0,"shares_display":"669","price_per_share":36.3,"price_display":"36.30","price_state":"stated","total_value":24284.7,"total_display":"24,284.70","total_whole":"24,285","shares_owned_after":11696.0,"shares_owned_after_display":"11,696","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-09","filed_date":"2022-02-11","scope":"insider"},{"id":5102958,"accession":"0001209191-21-054117","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-054117","line_url":"/filing/0001209191-21-054117#line-2","is_derivative":false,"issuer_cik":"0001341011","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001341011","owner_cik":"0001341011","owner_name":"North Annette","owner_display_name":"North Annette","owner_url":"/insider/0001341011","role":"Officer (EVP, General Counsel & Secty)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel & Secty)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel & Secty.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":80.0,"price_display":"80.00","price_state":"stated","total_value":800000.0,"total_display":"800,000.00","total_whole":"800,000","shares_owned_after":12365.0,"shares_owned_after_display":"12,365","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-30","filed_date":"2021-08-31","scope":"insider"},{"id":4837868,"accession":"0001209191-21-040984","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-040984","line_url":"/filing/0001209191-21-040984","is_derivative":false,"issuer_cik":"0001341011","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001341011","owner_cik":"0001341011","owner_name":"North Annette","owner_display_name":"North Annette","owner_url":"/insider/0001341011","role":"Officer (EVP, General Counsel & Secty)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel & Secty)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel & Secty.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":77.02886133333334,"price_display":"77.03","price_state":"stated","total_value":1155432.92,"total_display":"1,155,432.92","total_whole":"1,155,433","shares_owned_after":12365.0,"shares_owned_after_display":"12,365","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-15","filed_date":"2021-06-16","scope":"insider","n_lines":3},{"id":5037364,"accession":"0001209191-21-019268","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-019268","line_url":"/filing/0001209191-21-019268","is_derivative":false,"issuer_cik":"0001341011","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001341011","owner_cik":"0001341011","owner_name":"North Annette","owner_display_name":"North Annette","owner_url":"/insider/0001341011","role":"Officer (EVP, General Counsel & Secty)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel & Secty)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel & Secty.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":109.796974,"price_display":"109.80","price_state":"stated","total_value":2195939.48,"total_display":"2,195,939.48","total_whole":"2,195,939","shares_owned_after":11754.0,"shares_owned_after_display":"11,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-08","filed_date":"2021-03-09","scope":"insider","n_lines":5},{"id":5189928,"accession":"0001209191-21-007041","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-21-007041","line_url":"/filing/0001209191-21-007041","is_derivative":false,"issuer_cik":"0001341011","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001341011","owner_cik":"0001341011","owner_name":"North Annette","owner_display_name":"North Annette","owner_url":"/insider/0001341011","role":"Officer (EVP, General Counsel & Secty)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel & Secty)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel & Secty.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9016.0,"shares_display":"9,016","price_per_share":129.8789751552795,"price_display":"129.88","price_state":"stated","total_value":1170988.84,"total_display":"1,170,988.84","total_whole":"1,170,989","shares_owned_after":604.0,"shares_owned_after_display":"604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-02","scope":"insider","n_lines":6},{"id":5189899,"accession":"0001209191-21-007041","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-007041","line_url":"/filing/0001209191-21-007041","is_derivative":false,"issuer_cik":"0001341011","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001341011","owner_cik":"0001341011","owner_name":"North Annette","owner_display_name":"North Annette","owner_url":"/insider/0001341011","role":"Officer (EVP, General Counsel & Secty)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel & Secty)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel & Secty.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15984.0,"shares_display":"15,984","price_per_share":123.64701076076076,"price_display":"123.65","price_state":"stated","total_value":1976373.82,"total_display":"1,976,373.82","total_whole":"1,976,374","shares_owned_after":3813.0,"shares_owned_after_display":"3,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-02","scope":"insider","n_lines":4}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001595893","name":"Turning Point Therapeutics, Inc.","url":"/issuer/0001595893","role":"Officer (EVP & General Counsel)","n_filings":5,"first_seen":"2021-02-02","last_seen":"2022-02-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001341011","retrieved_at":"2026-08-26T23:09:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}